Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer

Hsulf-1 is a newly identified enzyme, which has the ability to decrease the growth of hepatocellular, ovarian, and head and neck squamous cell carcinoma cells by interfering with heparin-binding growth factor signaling. Since pancreatic cancers over-express a number of heparin-binding growth factors...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Li, Junsheng, Kleeff, Jörg, Abiatari, Ivane, Kayed, Hany, Giese, Nathalia A, Felix, Klaus, Giese, Thomas, Büchler, Markus W, Friess, Helmut
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2005
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1087876/
https://ncbi.nlm.nih.gov/pubmed/15817123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-4-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars